GILEA, ALEXANDRU IONUT
 Distribuzione geografica
Continente #
NA - Nord America 1.039
AS - Asia 969
EU - Europa 611
SA - Sud America 180
Continente sconosciuto - Info sul continente non disponibili 51
AF - Africa 49
OC - Oceania 3
Totale 2.902
Nazione #
US - Stati Uniti d'America 998
SG - Singapore 335
IT - Italia 312
VN - Vietnam 200
CN - Cina 166
BR - Brasile 101
HK - Hong Kong 78
BD - Bangladesh 64
DE - Germania 61
CL - Cile 50
FR - Francia 41
IE - Irlanda 37
ZA - Sudafrica 31
NL - Olanda 30
GB - Regno Unito 29
SE - Svezia 23
CA - Canada 21
IN - India 21
KR - Corea 15
MX - Messico 15
FI - Finlandia 14
JP - Giappone 13
AR - Argentina 12
RU - Federazione Russa 12
PK - Pakistan 10
ES - Italia 9
PL - Polonia 9
AT - Austria 8
PH - Filippine 8
ID - Indonesia 7
EC - Ecuador 6
IQ - Iraq 6
CI - Costa d'Avorio 5
CZ - Repubblica Ceca 5
IL - Israele 5
TR - Turchia 5
TW - Taiwan 5
VE - Venezuela 5
AZ - Azerbaigian 4
LT - Lituania 4
SA - Arabia Saudita 4
TN - Tunisia 4
UZ - Uzbekistan 4
AU - Australia 3
DK - Danimarca 3
JM - Giamaica 3
MY - Malesia 3
NP - Nepal 3
TH - Thailandia 3
BE - Belgio 2
CO - Colombia 2
CR - Costa Rica 2
EG - Egitto 2
ET - Etiopia 2
GE - Georgia 2
GY - Guiana 2
MA - Marocco 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
CH - Svizzera 1
HR - Croazia 1
IR - Iran 1
JO - Giordania 1
KE - Kenya 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MT - Malta 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
SC - Seychelles 1
SI - Slovenia 1
Totale 2.851
Città #
Singapore 182
Ashburn 142
San Jose 111
Santa Clara 80
Dallas 76
Hong Kong 72
Ho Chi Minh City 71
Council Bluffs 52
Parma 48
Los Angeles 47
Chandler 43
Beijing 42
Hanoi 41
Dublin 37
Boardman 34
New York 32
Johannesburg 26
Milan 26
Santiago 26
Hefei 23
Rome 21
Shanghai 20
Bologna 19
Buffalo 19
Catania 16
Haiphong 15
Lauterbourg 15
Orem 14
Nuremberg 13
Seoul 12
Piacenza 11
Houston 10
London 10
Munich 10
Padova 10
São Paulo 10
Tokyo 10
Vitacura 10
Chicago 9
Columbus 9
Berlin 7
Boston 7
Brescia 7
Frankfurt am Main 7
Gravina di Catania 7
Sassuolo 7
Toronto 7
Warsaw 7
Helsinki 6
Jakarta 6
Turku 6
Abidjan 5
Amsterdam 5
Da Nang 5
Denver 5
Des Moines 5
Lucca 5
Mexico City 5
Moscow 5
Palermo 5
Rancagua 5
San Francisco 5
The Dalles 5
Turin 5
Vienna 5
Ann Arbor 4
Atlanta 4
Avola 4
Baku 4
Brasília 4
Fresno 4
Genoa 4
Langhirano 4
Messina 4
Mumbai 4
Naples 4
Philadelphia 4
Princeton 4
Baghdad 3
Be'er Ya'aqov 3
Belo Horizonte 3
Cape Town 3
Castenedolo 3
Cesenatico 3
Curitiba 3
Guarulhos 3
Istanbul 3
João Pessoa 3
Juneau 3
Kingston 3
Lahore 3
Lincoln 3
Mardan 3
Melbourne 3
Montreal 3
Olomouc 3
Pessano Con Bornago 3
Phoenix 3
Pittsburgh 3
Querétaro 3
Totale 1.736
Nome #
Yeast-Based Functional Investigation of ELAC2 Variants in Mitochondrial Dysfunction 252
A yeast-based repurposing approach revealed modulation of dNTP pool as a therapeutic target to treat mitochondrial DNA depletion syndromes 221
Drug Drop Test: How to Quickly Identify Potential Therapeutic Compounds for Mitochondrial Diseases Using Yeast Saccharomyces cerevisiae 182
Exploring Yeast as a Study Model of Pantothenate Kinase-Associated Neurodegeneration and for the Identification of Therapeutic Compounds 180
Functional characterization of archaic-specific variants in mitonuclear genes: insights from comparative analysis in S. cerevisiae 167
A steric gate prevents mutagenic dATP incorporation opposite 8-oxo-deoxyguanosine in mitochondrial DNA polymerases 162
Saccharomyces cerevisiae as a tool for studying mutations in nuclear genes involved in diseases caused by mitochondrial DNA instability 157
Identification of drugs for the treatment of POLG-related diseases by means of a high throughput drug repurposing approach performed in Saccharomyces cerevisiae 144
Zebrafish polg2 knock-out recapitulates human POLG-disorders; implications for drug treatment 142
A simple organism to address big questions: how Saccharomyces cerevisiae can support mitochondrial medicine 138
Multicystic Interstitial Lung Disease Due to a Novel Biallelic C-C Chemokine Receptor Type 2 Variant 134
Transcriptomics on yeast models to deepen the knowledge of mitochondrial disease-associated pathways 131
The absence of SNF8 in the yeast Saccharomyces cerevisiae leads to mitochondrial dysfunction 131
Modopathies Caused by Mutations in Genes Encoding for Mitochondrial RNA Modifying Enzymes: Molecular Mechanisms and Yeast Disease Models 130
The yeast Saccharomyces cerevisiae as a model to deepen the knowledge about the mitochondrial metallopeptidase PITRM1 in health and disease 112
Severe mitochondrial encephalomyopathy caused by de novo variants in OPA1 gene 102
The Saccharomyces cerevisiae mitochondrial DNA polymerase and its contribution to the knowledge about human POLG-related disorders 101
Identification of drugs for the treatment of POLG-related diseases by means of a high throughput drug repurposing approach performed in Saccharomyces cerevisiae 98
Yeast as a model for searching drugs against pathologies caused by mutations in ACO2 96
Functional characterization of archaic-specific variants in mitonuclear genes: power of the yeast model 65
Decoding mitochondrial disorders using Saccharomyces cerevisiae 19
Yeast-based functional investigation of WARS2 variants and amino acid supplementation as a therapeutic strategy 18
Saccharomyces cerevisiae as a tool for the modeling of variants and the functional analysis of genes associated with mitochondrial diseases 13
Progressive cognitive impairment and ventricular tachycardia in a boy with biallelic POLG variants and a de novo RYR2 variation 7
Totale 2.902
Categoria #
all - tutte 8.794
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.794


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202229 0 0 0 0 3 6 3 1 4 0 0 12
2022/2023163 10 15 24 6 5 14 20 8 47 0 6 8
2023/2024147 7 8 8 3 5 20 12 7 1 24 9 43
2024/2025665 24 16 20 41 86 110 36 36 98 42 45 111
2025/20261.709 142 125 179 164 200 102 167 78 240 108 130 74
2026/2027160 78 82 0 0 0 0 0 0 0 0 0 0
Totale 2.902